References
- 1. HUNDER GG., BLOCH DA., MICHEL BA., STEVENS MB., AREND WP., CALABRESE LH., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33(8):1122.
- 2. ARIDA A., KYPRIANOU M., KANAKIS M., SFIKAKIS PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010; 11:44.
- 3. SMETANA GW., SHMERLING RH. The rational clinical examination. Does this patient have temporal arteritis? JAMA. 2002; 287(1):92–101.
- 4. BALL E.L., WALSH S. R., TANG TY., GOHIL R., CLARKE JM. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg. 2010; 97(12):1765–71.
- 5. ASCHWANDEN M., DAIKELER T., KESTEN F., BALDI T., BENZ D., TYNDALL A., et al. Temporal artery compression sign – a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013; 34(1):47–50.
- 6. HISHAM M., HABIB AA., ESSA AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol. 2012 Feb; 31(2):231–7.
- 7. LARIA A., LURATI A., SCARPELLINI M. Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up. Open Access Rheumatol. 2017; 15 (9):55–59.
- 8. SCHMIDT WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology (Oxford). 2018; 57(2):ii22–ii31.
- 9. DE MIGUEL E., ROXO A., CASTILLO C., PEITEADO D., VILLALBA A., MARTÍN-MOLA E. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol. 2012; 30(1 Suppl 70):34–8.
- 10. SANTORO L., D’ONOFRIO F., BERNARDI S., GREMESE E., FERRACCIOLI G., SANTOLIQUIDO A. Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment. Rheumatology (Oxford). 2013; 52(4):622.
- 11. KARASSA FB., MATSAGAS MI., SCHMIDT WA., IOANNIDIS JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005; 142(5):359–69.
- 12. RINAGEL M., CHATELUS E., JOUSSE-JOULIN S., SIBILIA J., GOTTENBERG JE., CHASSET F., et al. Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev. 2019; 18(1):56–61.
- 13. PROVEN A., GABRIEL SE., ORCES C, O’FALLON WM., HUNDER GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003; 49(5):703.
- 14. FRASER JA., WEYAND CM., NEWMAN NJ., BIOUSSE V. The treatment of giant cell arteritis. Rev Neurol Dis. 2008; 5(3): 140–152.
- 15. AIELLO PD., TRAUTMANN JC., MCPHEE TJ., KUNSELMAN AR., HUNDER GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993; 100(4):550.
- 16. BUTTGEREIT F., DEJACO C., MATTESON EL., DASGUPTA B. Polymyalgia rheumatica and giant cell arteritis a systematic review. JAMA. 2016; 315(22):2442–58Cl.
- 17. CAMPBELL AM., MARTIN JR., ERSTAD BL. Corticosteroid tapering regimens in rheumatic disease: a systematic review.; J Clin Rheumatol. 2018 (Volume published ahead of print).
- 18. CHANDRAN A., UDAYAKUMAR PD., KERMANI TA., WARRINGTON KJ., CROWSON CS., MATTESON EL. Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009). Clin Exp Rheumatol. 2015; 33(2):98–102.